WASHINGTON, Aug. 8, 2017 /PRNewswire/ -- Rowley Law PLLC
is investigating potential claims against NxStage Medical, Inc.
(NASDAQ: NXTM) and its board of directors for breach of
fiduciary duty concerning the proposed acquisition of the company
by Fresenius Medical Care for $30.00
per share in cash. The transaction is valued at approximately
$2 billion and is expected to close
in 2018.
If you are a NxStage Medical, Inc. shareholder and are
interested in obtaining additional information regarding this
investigation, please visit us at:
http://www.rowleylawpllc.com/investigation/nxstage. You may
also contact Danielle Rowland Lindahl,
Esq. at Rowley Law PLLC, 2316 Rhode Island Ave NE,
Washington, DC 20018, by email at
info@rowleylawpllc.com, or by telephone at 202-800-3501 or
844-400-4643 (toll-free).
Rowley Law PLLC represents shareholders nationwide in class
actions and derivative lawsuits in complex corporate litigation.
For more information about the firm and its attorneys, please visit
http://www.rowleylawpllc.com.
Attorney Advertising. Prior results do not guarantee a similar
outcome.
View original
content:http://www.prnewswire.com/news-releases/rowley-law-pllc-is-investigating-nxstage-medical-inc-and-its-board-of-directors-for-potential-breaches-of-fiduciary-duty-300501327.html
SOURCE Rowley Law PLLC